Recombinant Borrelia hermsii Elongation factor Ts (tsf)

What is Elongation factor Ts (tsf) and what is its primary function in Borrelia hermsii?

Elongation factor Ts (EF-Ts) is a critical protein involved in the translation elongation cycle of protein synthesis in Borrelia hermsii. Its primary function is to catalyze the regeneration of active EF-Tu-GTP from inactive EF-Tu-GDP, thereby enabling the continuous delivery of aminoacyl-tRNAs to the ribosome during protein synthesis. In B. hermsii, a relapsing fever spirochete, this protein is encoded by the tsf gene and plays an essential role in maintaining translational efficiency. While most research on Borrelia has focused on virulence factors like FhbA , the fundamental translational machinery, including EF-Ts, remains vital for pathogen survival and adaptation during infection cycles between tick vectors and mammalian hosts.

What is the molecular structure and characteristics of B. hermsii Elongation factor Ts?

The B. hermsii Elongation factor Ts (tsf) is a full-length protein comprising 278 amino acids with a molecular weight of approximately 30-32 kDa. Its primary sequence includes multiple functional domains typical of bacterial EF-Ts proteins. The complete amino acid sequence is as follows:

MSISPQEVKK LRDATGAGFG DCKKALDAVG GDFELAKKKL REMGIASADK RSGRDAKEGR VFSYVNKERV GLLLISCETD FVAMNGDFVT FGNSLIKQLV ESGKDSLDEQ QELEIKNLAA TIKENIHVSK IYISNIASNE LVKNYLHGEQ SKIGVFIKLR VDDVLKIEDG SLNSLTMDLA LHVAAFAPLY LSVGDVCPNY IKEQEEVFMK QMEASGKPEN VIKGIVSGKL KKHLGEITLL EQGFVKDDKL TVKEKIEEVS KSILTKIEII DFKYFSVG

Unlike virulence factors that have been crystallized (such as FhbA with a unique alpha-helical fold ), the detailed three-dimensional structure of B. hermsii EF-Ts has not been specifically reported in the provided search results, though it likely shares structural features with other bacterial EF-Ts proteins.

How does B. hermsii Elongation factor Ts differ from homologous proteins in other bacterial species?

While the provided search results don't directly compare B. hermsii EF-Ts with homologs from other species, general principles of bacterial EF-Ts evolution suggest species-specific adaptations. B. hermsii, as a relapsing fever spirochete, has evolved within a specialized niche requiring adaptation to both arthropod and vertebrate host environments. This evolutionary pressure likely resulted in unique sequence features of its EF-Ts that optimize translation under the varying temperature and metabolic conditions encountered during its lifecycle. Comparative analysis with other spirochete EF-Ts proteins would be valuable for identifying conserved regions essential for function versus variable regions that may reflect species-specific adaptations. Such analysis would complement the current focus on virulence factors like FhbA, which has been extensively studied for its role in complement evasion .

How can recombinant B. hermsii Elongation factor Ts be utilized to study spirochete protein synthesis mechanisms?

Recombinant B. hermsii EF-Ts can serve as a valuable tool for investigating spirochete-specific protein synthesis mechanisms through several experimental approaches:

• In vitro translation systems: Purified recombinant EF-Ts can be incorporated into reconstituted translation systems to study the kinetics and efficiency of B. hermsii protein synthesis under controlled conditions.

• Interaction studies: The recombinant protein can be used in binding assays to identify interactions with other components of the translation machinery, including EF-Tu, ribosomes, and potentially regulatory factors.

• Inhibitor screening: The purified protein allows for high-throughput screening of small molecules that might specifically interfere with spirochete translation, potentially leading to new antimicrobial strategies.

• Structural biology approaches: Highly purified recombinant EF-Ts (>85% purity by SDS-PAGE ) is suitable for crystallization trials to determine its three-dimensional structure, complementing existing structural studies of other Borrelia proteins like FhbA .

• Temperature-dependent activity assays: Given the temperature shifts B. hermsii experiences between tick vectors and mammalian hosts, functional assays at different temperatures could reveal adaptations in its translational machinery.

These approaches may uncover spirochete-specific translation mechanisms that could be exploited therapeutically, similar to how research on FhbA has revealed mechanisms of immune evasion .

What insights can functional studies of Elongation factor Ts provide about B. hermsii's adaptation during its infectious cycle?

Functional studies of EF-Ts can provide several insights into B. hermsii adaptation during its infectious cycle:

• Temperature adaptation: By comparing the activity and stability of recombinant EF-Ts at different temperatures (23-25°C for tick environments versus 37°C for mammalian hosts), researchers can understand how protein synthesis is maintained across these temperature shifts.

• Nutrient limitation response: Assessing EF-Ts function under varying nutrient conditions can reveal how B. hermsii maintains essential protein synthesis during nutrient limitation encountered in different host environments.

• Stress response roles: Evaluating if EF-Ts expression or activity changes during different stress conditions might uncover additional regulatory roles beyond its canonical function in translation.

• Cross-species functionality: Testing whether B. hermsii EF-Ts can functionally complement EF-Ts deficiencies in other bacteria may reveal spirochete-specific adaptations of the protein synthesis machinery.

• Potential target for intervention: If B. hermsii EF-Ts displays unique structural or functional features compared to mammalian elongation factors, it might represent a potential target for selective inhibition.

These studies would complement current research on virulence factors like FhbA, which has been shown not to be required for infectivity in mouse models despite its role in complement evasion .

How might Elongation factor Ts interact with the antigenic variation mechanisms of B. hermsii?

B. hermsii employs multiphasic antigenic variation of Vsp and Vlp proteins to evade host immune responses during relapsing fever infections . The relationship between Elongation factor Ts and this antigenic variation system presents an intriguing research question:

• Translation efficiency of variant proteins: EF-Ts may play a crucial role in the efficient translation of newly activated variable surface proteins during antigenic switching events. Research could investigate whether the translation machinery, including EF-Ts, is optimized for the rapid expression of these variable antigens.

• Coordination with genetic recombination: The timing of antigenic switching involves genetic recombination events, and studies could explore whether translation factors like EF-Ts are coordinately regulated with the recombination machinery.

• Stress response connection: Antigenic variation might be triggered by host immune stress, and EF-Ts could be part of a broader stress response that coordinates immune evasion strategies.

• Comparative translation studies: Comparing the translation efficiency of Vsp/Vlp proteins versus constitutive proteins might reveal whether specialized translation mechanisms facilitate antigenic variation.

• Potential regulatory roles: Beyond its canonical role in translation, EF-Ts might have moonlighting functions that contribute to the regulation of antigenic variation, similar to how some translation factors in other organisms have secondary regulatory roles.

This research direction could provide insights into how the basic translational machinery integrates with sophisticated immune evasion mechanisms, complementing the current understanding of B. hermsii FhbA and its complex role in pathogenesis .

What are the optimal conditions for expression and purification of recombinant B. hermsii Elongation factor Ts?

Based on the available information, here are the optimal conditions for expression and purification of recombinant B. hermsii Elongation factor Ts:

• Expression system: Baculovirus expression system has been successfully used for the production of recombinant B. hermsii EF-Ts, which allows for proper folding and potential post-translational modifications .

• Purification strategy: The recombinant protein can be purified to >85% homogeneity using SDS-PAGE analysis . While specific purification protocols aren't detailed in the search results, standard approaches typically include:

  • Affinity chromatography using a tag (specific tag information would be determined during manufacturing)

  • Ion exchange chromatography

  • Size exclusion chromatography for final polishing

• Storage conditions: For optimal stability, the purified protein should be stored at -20°C, with extended storage at -20°C or -80°C. Working aliquots can be maintained at 4°C for up to one week .

• Reconstitution protocol: The lyophilized protein should be reconstituted in deionized sterile water to a concentration of 0.1-1.0 mg/mL. Addition of glycerol to a final concentration of 5-50% (optimally 50%) is recommended for long-term storage at -20°C/-80°C .

• Shelf life: The reconstituted protein in liquid form typically has a shelf life of approximately 6 months at -20°C/-80°C, while the lyophilized form remains stable for about 12 months at -20°C/-80°C .

These methodological details ensure the production of high-quality recombinant protein suitable for structural and functional studies.

How can researchers effectively use recombinant EF-Ts in studies of B. hermsii pathogenesis and immune evasion?

Researchers can employ recombinant B. hermsii EF-Ts in several ways to investigate pathogenesis and immune evasion:

• Comparative studies with virulence factors: While EF-Ts is not a classical virulence factor like FhbA, comparative analysis of translation efficiency between housekeeping proteins and virulence factors could reveal whether protein synthesis is prioritized during infection. This approach has been valuable in understanding virulence mechanisms in other pathogens.

• Immunological studies: Determining whether EF-Ts elicits an immune response during infection could provide insights into host recognition of conserved bacterial proteins. Unlike the highly variable surface antigens, conserved proteins like EF-Ts might be targets for cross-protective immunity.

• Growth under stress conditions: Using recombinant EF-Ts in complementation studies could reveal how protein synthesis adapters to stress conditions encountered during infection, such as nutrient limitation, oxidative stress, or temperature shifts.

• Integration with genetic manipulation approaches: The genetic manipulation systems developed for B. hermsii, such as those used to generate the FhbA deletion mutant , could be applied to modify tsf expression levels to assess the impact on growth and pathogenesis.

• Functional studies in heterologous systems: Similar to how Vsp proteins have been expressed in B. burgdorferi for functional studies , EF-Ts could be expressed in heterologous systems to assess functional conservation across spirochetes.

These approaches would complement the existing methodologies used in studying B. hermsii virulence factors.

What genetic manipulation techniques are available for studying the tsf gene in B. hermsii?

Several genetic manipulation techniques have been developed for Borrelia species that could be applied to study the tsf gene in B. hermsii:

These genetic manipulation techniques represent significant technological advances in the field, as noted in the literature: "this study represents an important technological step forward, as it is the first report to describe the inactivation of a B. hermsii virulence factor and subsequent analysis of the resulting mutant in an animal model."

What role might B. hermsii Elongation factor Ts play in development of new diagnostic tools for relapsing fever?

Recombinant B. hermsii Elongation factor Ts has several potential applications in diagnostic development:

• Serological diagnostics: As a conserved protein, EF-Ts might serve as a diagnostic antigen for detecting antibodies against B. hermsii in patient samples. Unlike highly variable surface antigens, conserved proteins could provide more consistent detection across different strains and stages of infection. This approach would be complementary to using FhbA as a diagnostic antigen, which has been explored for B. hermsii infection in humans .

• Differential diagnostics: Comparative analysis of antibody responses to EF-Ts from different Borrelia species might help distinguish between relapsing fever and Lyme disease borreliosis, addressing a significant diagnostic challenge.

• PCR-based detection: The tsf gene sequence could be used to design species-specific primers for molecular detection of B. hermsii in clinical or environmental samples, potentially offering improved sensitivity or specificity compared to existing targets.

• Protein-based detection systems: Recombinant EF-Ts could be utilized in developing aptamer or antibody-based detection systems targeting Borrelia proteins directly in patient samples.

• Multiplex assay components: Including EF-Ts alongside virulence factors like FhbA in multiplex detection platforms might improve diagnostic accuracy by targeting both conserved and variable Borrelia proteins.

The development of such diagnostic tools would be particularly valuable given the challenges in diagnosing relapsing fever borreliosis and distinguishing it from other febrile illnesses.

How could comparative studies of Elongation factor Ts across Borrelia species inform evolution of pathogenesis mechanisms?

Comparative studies of EF-Ts across Borrelia species could provide valuable insights into evolutionary adaptations of these spirochetes:

• Translational adaptation signatures: Sequence and functional variations in EF-Ts across Borrelia species that cause different diseases (relapsing fever versus Lyme disease) might reflect adaptation to different host environments and transmission cycles.

• Host-pathogen co-evolution: Comparing EF-Ts from Borrelia species with different host ranges could reveal signatures of co-evolution with host translation systems, particularly at interaction interfaces with host factors.

• Phylogenetic relationships: The conservation patterns of essential genes like tsf could provide insights into the evolutionary relationships among Borrelia species, complementing studies of more variable genes.

• Horizontal gene transfer assessment: Analysis of tsf and surrounding genetic regions might reveal instances of horizontal gene transfer that have contributed to pathogen evolution.

• Functional conservation testing: Experimental assessment of whether EF-Ts proteins are functionally interchangeable across Borrelia species would reveal the degree of functional conservation despite sequence divergence.

Such comparative approaches have proven valuable in studying immune evasion mechanisms, as demonstrated by the identification of a new family of FhbA-related immune evasion molecules from both Lyme disease and relapsing fever Borrelia through structure-guided sequence database analysis .

What potential exists for developing antimicrobial strategies targeting Elongation factor Ts in Borrelia species?

The essential role of Elongation factor Ts in bacterial protein synthesis makes it a potential target for novel antimicrobial strategies:

• Small molecule inhibitors: The recombinant protein could be used in high-throughput screening assays to identify compounds that specifically inhibit B. hermsii EF-Ts function without affecting the human homolog.

• Peptide inhibitors: Based on structural studies of EF-Ts interactions with binding partners, peptide inhibitors could be designed to disrupt these essential protein-protein interactions.

• RNA-based approaches: Antisense RNA or aptamers targeting the tsf mRNA or protein could be explored as alternative therapeutic strategies, potentially delivered via nanoparticles or phage-based systems.

• Structure-based drug design: If the three-dimensional structure of B. hermsii EF-Ts is determined, computational approaches could identify potential binding pockets for small molecule inhibitors.

• Phage therapy approaches: The growing interest in phage therapy for borreliosis could potentially incorporate strategies targeting essential genes like tsf, possibly through phage-delivered inhibitors or CRISPR-Cas systems.

Development of such targeted approaches would be valuable given the challenges of current antibiotic treatments and the potential for resistance development. As noted in recent research: "our results could potentially contribute to the development of targeted treatment for borreliosis through phage therapy... which could reduce the reliance on antibiotics in the future."

What are the key specifications and handling protocols for working with recombinant B. hermsii Elongation factor Ts?

The following table summarizes the key specifications and handling protocols for recombinant B. hermsii Elongation factor Ts:

For optimal results when working with this protein:

• Avoid repeated freeze-thaw cycles by preparing working aliquots during initial reconstitution

• Centrifuge the vial briefly before opening to bring contents to the bottom

• When using for immunological applications, consider that the tag type (if present) may influence antibody recognition

• Follow standard laboratory protocols for handling purified recombinant proteins

• Consider the potential impact of buffer components when designing experimental assays

These specifications ensure consistent and reliable results when utilizing this recombinant protein in research applications.

How can researchers troubleshoot common issues when working with recombinant Borrelia proteins?

Researchers may encounter several challenges when working with recombinant Borrelia proteins, including EF-Ts. Here are evidence-based troubleshooting approaches:

• Low protein solubility:

  • Optimize buffer conditions (pH, salt concentration, reducing agents)

  • Consider fusion tags that enhance solubility (such as MBP or SUMO)

  • Explore refolding protocols if the protein forms inclusion bodies

  • Test expression at lower temperatures to improve folding

• Protein degradation:

  • Include protease inhibitors in all buffers

  • Minimize handling time at room temperature

  • Consider point mutations to remove protease-sensitive sites without affecting function

  • Optimize storage conditions with stabilizers like glycerol (5-50%)

• Low transformation efficiency when expressing in Borrelia:

  • Pre-methylate plasmid DNA to protect from restriction enzymes (shown to increase efficiency from 0.5±0.5 to 3.5±1.5 positive wells)

  • Consider restriction-modification systems present in the target Borrelia strain

  • Optimize electroporation parameters specifically for the target strain

  • Use low-passage infectious isolates for more consistent results

• Inconsistent functional assays:

  • Ensure protein quality through multiple analytical methods (SDS-PAGE, size exclusion chromatography)

  • Control for the effects of tags on protein function

  • Include appropriate positive and negative controls in all assays

  • Consider the impact of buffer components on protein activity

• Cross-reactivity in immunological applications:

  • Pre-absorb antibodies against common bacterial proteins

  • Use carefully designed antigenic peptides rather than whole proteins

  • Validate antibody specificity against multiple Borrelia species

  • Consider the potential impact of post-translational modifications

These troubleshooting approaches are informed by the techniques that have been successfully applied to other Borrelia proteins, such as FhbA and surface lipoproteins .

What are the current limitations in research of B. hermsii Elongation factor Ts and how might they be addressed?

Current research on B. hermsii Elongation factor Ts faces several limitations that could be addressed through methodological advances:

• Limited structural information:

  • Challenge: Unlike some virulence factors like FhbA that have been crystallized , detailed structural information for B. hermsii EF-Ts is lacking.

  • Solution: Apply cryo-electron microscopy or X-ray crystallography to determine the three-dimensional structure, potentially revealing unique features compared to homologs from other species.

• Genetic manipulation challenges:

  • Challenge: Genetic modification of B. hermsii remains technically challenging, with researchers noting: "Primarily due to the lack of well-developed genetic manipulation systems for the TBRF spirochetes..."

  • Solution: Adapt recent advances in transformation efficiency optimization specifically for tsf studies, including pre-methylation of plasmid DNA and consideration of restriction-modification systems.

• Essential gene targeting:

  • Challenge: As an essential gene, direct knockout of tsf would likely be lethal, complicating functional studies.

  • Solution: Develop conditional expression systems or partial loss-of-function mutations to study tsf without compromising viability.

• In vivo relevance:

  • Challenge: Connecting in vitro findings to in vivo significance remains difficult.

  • Solution: Develop animal models with reporter systems to monitor translation efficiency during infection, similar to approaches used for studying the FhbA deletion mutant in vivo .

• Integration with systems biology:

  • Challenge: Studies of individual proteins often lack context within broader cellular networks.

  • Solution: Incorporate proteomics and transcriptomics approaches to understand how EF-Ts functions within the larger context of B. hermsii adaptation during its infectious cycle.

These limitations can be addressed through collaborative approaches combining expertise in structural biology, genetic manipulation, and animal models, as has been successfully done for other Borrelia virulence factors .